We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia (LLC2007SA)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00645606
First Posted: March 27, 2008
Last Update Posted: August 1, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Roche Pharma AG
French Innovative Leukemia Organisation
Information provided by (Responsible Party):
University Hospital, Tours
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2017
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)